CD147-CAR T cells
/ Peking University People's Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 03, 2022
CD147-CAR T Cells for Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma
(clinicaltrials.gov)
- P1 | N=12 | Not yet recruiting | Sponsor: Peking University People's Hospital | Trial completion date: Jan 2024 ➔ Jan 2025 | Initiation date: Oct 2021 ➔ Jan 2023 | Trial primary completion date: Jan 2023 ➔ Jan 2024
CAR T-Cell Therapy • Trial completion date • Trial initiation date • Trial primary completion date • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • T Cell Non-Hodgkin Lymphoma • ALK • BSG
1 to 1
Of
1
Go to page
1